“We also are also pleased the panel recognized the important safer alternative design theory underpinning the lower dose injectable Depo Sub Q Provera 104, and limited the MDL to the salient ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果